Mature and Diverse Pipeline

Novexel's goal is to discover and develop innovative treatments for infectious diseases which tackle the ever increasing problem of bacterial resistance.

Novexel owns all rights to the programmes outlined below, except where indicated.

Tackling serious bacterial and fungal infections is a high priority for most countries' health authorities and Novexel is focused on producing innovative products for meeting the specific needs of hospitals: